Arrowstreet Capital Limited Partnership reduced its position in shares of HCA Healthcare Inc (NYSE:HCA) by 10.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,980,955 shares of the company’s stock after selling 339,485 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in HCA Healthcare were worth $261,847,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Strs Ohio boosted its holdings in HCA Healthcare by 12.2% in the 3rd quarter. Strs Ohio now owns 1,075,778 shares of the company’s stock valued at $85,621,000 after purchasing an additional 117,000 shares during the period. Cryder Capital Partners LLP boosted its holdings in HCA Healthcare by 37.6% in the 4th quarter. Cryder Capital Partners LLP now owns 507,406 shares of the company’s stock valued at $44,571,000 after purchasing an additional 138,780 shares during the period. AustralianSuper Pty Ltd bought a new stake in HCA Healthcare in the 3rd quarter valued at $24,410,000. Yellowstone Partners LLC bought a new stake in HCA Healthcare in the 3rd quarter valued at $5,802,000. Finally, Janus Henderson Group PLC boosted its holdings in HCA Healthcare by 50.3% in the 3rd quarter. Janus Henderson Group PLC now owns 523,063 shares of the company’s stock valued at $41,630,000 after purchasing an additional 175,158 shares during the period. 75.49% of the stock is owned by institutional investors and hedge funds.
A number of brokerages have weighed in on HCA. Jefferies Group reduced their price target on shares of HCA Healthcare from $90.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, November 1st. Wells Fargo & Co began coverage on shares of HCA Healthcare in a report on Tuesday, January 30th. They issued an “outperform” rating and a $116.00 price target for the company. SunTrust Banks set a $105.00 price target on shares of HCA Healthcare and gave the company a “buy” rating in a report on Thursday, December 21st. Sanford C. Bernstein reissued a “market perform” rating and issued a $116.00 price target (up from $105.00) on shares of HCA Healthcare in a report on Thursday, February 1st. Finally, Argus set a $97.00 price target on shares of HCA Healthcare and gave the company a “buy” rating in a report on Wednesday, January 10th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have issued a buy rating to the company’s stock. HCA Healthcare presently has an average rating of “Buy” and an average price target of $104.50.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 30th. The company reported $2.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.25. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The company had revenue of $11.56 billion during the quarter, compared to analysts’ expectations of $11.19 billion. During the same quarter in the prior year, the company posted $1.80 EPS. The business’s revenue was up 8.7% on a year-over-year basis. sell-side analysts forecast that HCA Healthcare Inc will post 8.71 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be paid a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend is Wednesday, February 28th.
In related news, SVP Sandra L. Morgan sold 3,698 shares of the stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $96.91, for a total transaction of $358,373.18. Following the completion of the sale, the senior vice president now owns 5,410 shares in the company, valued at approximately $524,283.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $78.00, for a total transaction of $167,700.00. Following the sale, the insider now owns 12,476 shares of the company’s stock, valued at approximately $973,128. The disclosure for this sale can be found here. Insiders have sold a total of 396,106 shares of company stock valued at $39,582,273 in the last quarter. 2.90% of the stock is currently owned by corporate insiders.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.